Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 4
Submit an article Journal homepage
124
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Mitochondria as a Target for Inducing Death of Malignant Hematopoietic Cells

Eric Solary INSERM U517, IFR 100, 7 boulevard Jeanne d'Arc, 21000 Dijon, France
,
Ali Bettaieb Clinical Hematology, CHU Le Bocage, BP1542, 21034 Dijon cedex, France
,
Laurence Dubrez-Daloz c Ecole Pratique des Hautes Etudes, INSERM U517, IFR 100, 7 boulevard Jeanne d'Arc, 21000 Dijon, France
&
Laurent Corcos INSERM U517, IFR 100, 7 boulevard Jeanne d'Arc, 21000 Dijon, France
Pages 563-574 | Published online: 01 Jul 2009

  • Szewczyk, A. and Wojtczak, L. (2002) "Mitochondria as a pharmacological target". Pharmacological Review 54, 101-127.
  • Vayssiere, J.L., Petit, P.X., Risler, Y. and Mignotte, B. (1994) "Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40". Proceeding of the National Academy of Sciences of the USA 91, 11752-11756.
  • Ott, M., Robertson, J.D., Gogvadze, V, Zhivotovsky, B. and Orrenius, S. (2002) "Cytochrome c release from mitochondria proceeds by a two-step process". Proceeding of the National Academy of Sciences of the USA 99, 1259-1263.
  • Cain, K., Bratton, S.B. and Cohen, G.M. (2002) "The Apaf-1 apoptosome: a large caspase-activating complex". Biochimic 84, 203-214.
  • Garrido, C., Gurbuxani, S., Ravagnan, L., and Kroemer, G. (2001) "Heat shock proteins: endogenous modulators of apoptotic cell death". Biochemical Biophysical Research Communications 286, 433-442.
  • Bruey, J.M., Ducasse, C., Bonniaud, P., Ravagnan, L., Susin, S.A., Diaz-Latoud, C., Gurbaxani, S., Arrigo, A.P., Kroemer, G., Solary, E. and Garrido, C. (2000) "Hsp27 negatively regulates cell death by interacting with cytochrome c". Nature Cell Biology 2, 645-652.
  • Beere, H.M., Wolf, B.B., Cain, K., Mosser, D.D., Mahboubi, A., Kuwana, T. Tailor, P., Morimoto, R.I., Cohen, G.M. and Green, D.R. (2000) "Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome". Nature Cell Biology 2, 469-475.
  • Saleh, A., Srinivasula, S.M., Balkir, L., Robbins, P.D. and Alnemri, E.S. (2000) "Negative regulation of the Apaf-1 apoptosome by Hsp70". Nature Cell Biology, 2, 476-483.
  • Du, C., Fang, M., U. Y., Li, L. and Wang, X. (2000) "Smac, a mitochondrial protein that promotes cytochrome t-dependent caspase activation by eliminating IAP inhibition". Cell 102, 33-42.
  • Verhagen, A.M., Ekert, PG., Pakusch, M., Silke, J., Connolly, L.M., Reid, G.E., Moritz, R.L., Simpson, R.J. and Vaux, D.L. (2000) "Identification of DIABLO. a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins". Cell 102, 43-53.
  • Suzuki, Y. lmai, Y. Nakayama, H., Takahashi, K., Takio, K. and Takahashi, R. (2001) "A serine protease. HtrA2, is released from the mitochondria and interacts with XLAP, inducing cell death". Molecular Cell 8, 613-621.
  • Samali, A., Cai, J., Zhivotovsky, B., Jones, D.P. and Orrenius, S. (1999) "Presence of a pre-apoptotic complex of pro-caspase-3. Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells". EMBO Journal 18, 2040-2048.
  • Mannick, J.B., Schonhoff, C., Papeta, N., Ghafourifar, P., Szibor, M., Fang, K. and Gaston, B. (2001) "S-Nitrosylation of mitochondrial caspases". Journal of Cell Biology 154, 1111-1116.
  • Cande, C., Cohen, I., Daugas, E., Ravagnan, L., Larochette, N., Zamzami, N. and Kroemer, G. (2002) "Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria". Biochimie 84, 215-222.
  • Li, L.Y., Lun, X. and Wang, X. (2001) "Endonuclease G is an apoptotic DNase when released from mitochondria". Nature 412, 95-99.
  • Adams, J.M and Cory, S. (2001) "Life-or-death decisions by the Bcl-2 protein family". Trends in Biochemical Sciences 26, 61-66.
  • Strasser, A., Puthalakath, H., Bottillet, P., Huang, D.O., O'Connor, L., O'Reilly, L.A., Cullen, L., Cory, S. and Adams, J.M. (2000) "The role of him, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control". Annals of New York Academic of Science 917, 541-548.
  • Puthalakath, H., Villunger, A., O'Reilly, L.A., Beaumont, J.G., Coultas, L., Cheney, R.E., Huang, D.C. and Strasser, A. (2001) "Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis". Science 293, 1829-1832.
  • Zha, J., Harada, H., Yang, E., Jockel, J. and Korsmeyer, S.J. (1996) "Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)". Cell 87, 619-628.
  • Martinou, J.C., Green, D.R. (2001) "Breaking the mitochondrial barrier" Nature Review Molecular Cell Biology, 2. pp. 63-67.
  • Griffiths, G.J., Dubrez, L., Morgan, C.P., Jones, N.A., Whitehouse, J., Corfe, B.M., Dive, C. and Hickman, J.A. (1999) "Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis". Journal of Cell Biology 144, 903-914.
  • Schuler, M. and Green, D.R. (2001) "Mechanisms of p53-dependent apoptosis". Biochemical Society Transactions 29, 684-688.
  • Desagher, S., Osen-Sand, A., Montessuit, S., Magnenat, E., Vilbois, F., Hochmann, A., Journot, L., Antonsson, B. and Martinou, J.C. (2001) "Phosphorylation of bid by casein kinases 8, and II regulates its cleavage by caspase 8". Molecular Cell 8, 601-611.
  • Zha, J., Weiler, S., Oh, K.J., Wei, M.C. and Korsmeyer, S.J (2000) "Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis". Science 290, 1761-1765.
  • Marchenko, N.D., Zaika, A. and Moll, U.M. (2000) "Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling". Journal of Biological Chemistry 275, 16202-16212.
  • Li, H., Kolluri, S.K., Gu, J., Dawson, M.I., Cao, X., Hobbs, P.D., Lin, B., Chen, G., Lu, J., Lin, F., Xie, Z., Fontana, J.A., Reed, J.C. and Zhang, X. (2000) "Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3". Science 289, 1159-1164.
  • Aoki, H., Kang, P.M., Hampe, J., Yoshimora, K., Noma, T., Matsuzaki, M. and Izumo, S. (2002) "Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes". Journal of Biological Chemistry 277, 10244-10250.
  • Ito, Y., Pandey, P., Mishra, N., Kumar, S., Narula, N., Kharbanda, S., Saxena, S. and Kufe, D. (2001) "Targeting of the C-Abl tyrosine kinase to mitochondria in endoplasmic reticulum stress-induced apoptosis". Molecular Cell Biolology 21, 6233-16242.
  • Li, L., Lorenzo, P.S., Bogi, K., Blumberg, P.M. and Yuspa, S.H. (1999) "Protein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector". Molecular Cell Biology 19, 8547-8558.
  • Bernardi, P., Petronilli, V., Di Lisa, F. and Forte, M. (2001) "A mitochondrial perspective on cell death". Trends in Biochemical Sciences 26, 112-117.
  • Karuman, P., Gozani, O., Odze, R.D., Zhou, X.C., Zhu, H., Shaw, R., Brien, T.P., Bozzuto, C.D., Ooi, D., Cantley, L.C. and Yuan, J. (2001) "The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death". Molecular Cell 7, 1307-1319.
  • Donald, S.P., Sun, X.Y., Hu, C.A., Yu, J., Mei, J.M., Valle, D. and Phang, J.M. (2001) "Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species". Cancer Research 61, 1810-1815.
  • Wei, M.C., Zong, W.X., Cheng, E.H., Lindsten, T., Panoutsakopoulou, V. Ross, A.J., Roth, K.A., MacGregor, G.R., Thompson, C.B. and Korsmeyer, S.J. (2001) "Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death". Science 292, 727-730.
  • Martinez-Senac Mdel, M., Corbalan-Garcia, S. and Gomez-Fernandez, J.C. (2002) "The structure of the C-terminal domain of the pro-apoptotic protein Bak and its interaction with model membranes". Biophysical Journal 82, 233-243.
  • Zhang, L., Yu, J., Park, B.H., Kinzler, K.W. and Vogelstein, B. (2000) "Role of BAX in the apoptotic response to anticancer agents". Science 290, 989-992.
  • Madesh, M. and Hajnoczky. G. (2001) "VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release". Journal of Cell Biology 155, 1003-1015.
  • Brenner, C., Cadiou, H., Vieira, H.L., Zamzami, N., Marzo, I., Xie, Z., Leber, B., Andrews, D., Duclohier, H., Reed, J.C. and Kroemer, G. (2000) "Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator". Oncogene 19, 329-336.
  • Zamzami, N. and Kroemer, G. (2001) "The mitochondrion in apoptosis: how Pandora's box opens". Nature Review Molecular Cell Biology 2, 67-71.
  • Williams, S.D. and Gottlieb, R.A. (2002) "Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective". Biochemical Journal 362, 23-32.
  • Birbes, H., El Bawab, S., Hannun, Y.A. and Obeid, L.M. (2001) "Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis". FASEB Journal 15, 2669-2679.
  • Scorrano, L., Ashiya, M., Buttle, K., Weiler, S., Oakes, S.A., Mannella, C.A. and Korsmeyer, S.J. (2002) "A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis". Developmental Cell 2, 55-67.
  • Campos, L., Rouault, J.P., Sabido, O. Oriol, P., Roubi, N., Vasselon, C., Archimbaud, E., Magaud, J.P. and Guyotat, D. (1993) "High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy". Blood 81, 3091-3096.
  • Derenne, S., Monia, B., Dean, N.M., Taylor, J.K., Rapp, M.J. Harousseau, J.L., Bataille, R. and Amiot, M. (2002) "Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-X(L) is an essential survival protein of human myeloma cells". Blood 100, 194-199.
  • Kaufmann, S.H., Karp, J.E., Svingen, P.A., Krajewski, S., Burke, P.J., Gore, S.D. and Reed, J.C. (1998) "Elevated expression of the aptiptotic regulator Mcl-1 at the time of leukemic relapse". Blood 91, 991-1000.
  • Meijerink, J.P., Mensink, E.J., Wang, K., Sedlak, T.W., Sloetjes, A.W., de Witte, T., Waksman, G. and Korsmeyer, S.J. (1998) "Hematopoietic malignancies demonstrate loss-of-function mutations of BAX". Blood 91, 2991-2997.
  • Kusenda, J. (1998) "Bcl-2 family proteins and leukemia. Minireview". Neoplasma 45, 117-122.
  • Lipskaya, T.Yu., Geiger, P.J. and Bessman, S.P. (1995) "Compartmentation and metabolic parameters of mitochondrial hexokinase and creatine kinase depend on the rate of oxidative phosphorylation". Biochemical and Molecular Medecine 55, 81-89.
  • Czernin, J. and Phelps, M.E. (2002) "Positron emission tomography scanning: current and future applications". Annual Review of Medicine 53, 89-112.
  • Carayon, P., Portier, M., Dussossoy, D., Bord, A., Petitpretre, G., Canat, X., Le Fur, G. and Casellas, P. (1996) "Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage". Blood 87, 3170-3178.
  • Giraud, S., Bonod-Bidaud, C., Wesolowski-Louvel, M. and Stepien, G. (1998) "Expression of human ANT2 gene in highly proliferative cells: GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria". Journal of Molecular Biology 281, 409-418.
  • Pallis, M., Grundy, M., Turzanski, J., Kofler, R. and Russell, N. (2001) "Mitochondrial membrane sensitivity to depolarization in acute mycloblastic leukemia is associated with spontaneous in vitro apoptosis, wild-type TP53, and vicinal thiol/disulfide status". Blood 98, 405-413.
  • Singh, K.K., Russell, J., Sigala, B., Zhang, Y., Williams, J. and Keshav, K.F. (1999) "Mitochondrial DNA determines the cellular response to cancer therapeutic agents". Oncogene 18, 6641-6646.
  • Chandra, J., Mansson, E., Gogvadze, V., Kaufmann, S.H., Albertioni, F. and Orrenius, S. (2002) "Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release". Blood 99, 655-663.
  • Sordet, O., Rébé, C., Leroy, I., Bruey, J.M., Garrido, C., Miguet, C., Lizard, G., Plenchette, S., Corcos, L. and Solary, E. (2001) "Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis". Blood 97, 3931-3940.
  • Solary, E., Droin, N., Bettajeb, A., Corcos, L., Dimanche-Boitrel, MT. and Garrido, C. (2000) "Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies". Leukemia 14, 1833-1849.
  • Lin, J.H. and Castora, F.J. (1991) "DNA topoisomerase II from mammalian mitochondria is inhibited by the antitumor drugs, m-AMSA and VM-26". Biochemical Biophysical Research Communications 176, 690-697.
  • Robertson, J.D. Gogvadze, V., Zhivotovsky, B. and Orrenuis, S. (2000) "Distinct pathways for stimulation of cytochrome c release by etoposide". Journal of Biological Chemistry 275, 32438-32443.
  • Genini, D., Adachi, S., Chao, Q., Rose, D.W., Carrera, C.J., Cottam, H.B., Carson, D.A. and Leoni, L.M. (2000) "Deoxywadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria". Blood 96, 3537-3543.
  • Rodi, D.J., Janes, R.W., Sanganee, H.J., Holton, R.A., Wallace, B.A. and Makowski, L. (1999) "Screening of a library of phage-displayed peptides identities human bcl-2 as a taxol-binding protein". Journal of Molecular Biology 285, 197-203.
  • Shimizu, S., Narita, M. and Tsujimoto, Y. (1999) "Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC". Nature 399, 483-487.
  • Kidd, J.F., Pilkington, M.F., Schell, M.J., Fogarty, K.E., Skepper, J.N., Taylor, C.W. and Thorn, P. (2002) "Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore". Journal of Biological Chemistry 277, 6504-6510.
  • Fulda, S., Scaffidi, C., Susin, S.A., Krammer, P.M., Kroemer, G., Peter, M.E. and Debatin, K.M. (1998) "Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid". Journal of Biological Chemistry 273, 33942-33948.
  • Nagahara, Y., Ikekita, M. and Shinomiya, T. (2000) "Immunosuppressant FTY720 induces apoptosis by direct induction of permeability transition and release of cytochrome c from mitochondria". Journal of Immunology 165, 3250-3259.
  • Laurent, G. and Jaffrézou, J.P. (2001) "Signaling pathways activated by daunorubicin". Blood 98, 913-924.
  • Jung, K. and Reszka, R. (2001) "Mitochondria as subcellular targets for clinically useful anthracyclines". Advances in Drug Delivery Review 49, 87-105.
  • Nicolay, K., Timmers, R.J., Spoelstra, E., Van der Neut, R., Fok, J.J., Huigen, Y.M., Verkleij, A.J. and De Kruijff, B. (1984) "The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranes". Biochimica Biophysica Acta 778, 359-371.
  • Fry, M. and Green, D.E. (1981) "Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain". Journal of Biological Chemistry 256, 1874-1880.
  • Lenaz, G. (2001) "The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology". IUBMB Life 52, 159-164.
  • Davies, K.J. and Doroshow, J.H. (1986) "Redox cycling of anthracyclines by cardiac mitochondria. 1. Anthracycline radical formation by NADH dehydrogenase". Journal of Biological Chemistry 261, 3060-3067.
  • Kristal, B.S. and Brown, A.M. (1999) "Apoptogenic ganglioside GD3 directly induces the mitochondrial permeability transition". Journal of Biological Chemistry 274, 23169-23175.
  • Kroemer, G and de The, H. (1999) "Arsenic trioxide, a novel mitochondriotoxic anticancer agent?". Journal of Natural Cancer Institute 91, 743-745.
  • Akao, Y., Yamada, H. and Nakagawa, Y. (2000) "Arsenic-induced apoptosis in malignant cells in vitro". Leukemia and Lymphoma 37, 53-63.
  • Alemany, M. and Levin, J (2000) "The effects of arsenic trioxide (As2O3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages". Leukemia and Lymphoma 38, 153-163.
  • Zhu, J., Koken, M.H., Quignon, P., Chelbi-Alix, M.K., Degos, L., Wang, Z.Y., Chen, Z. and de The, H. (1997) "Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia". Proceeding of the National Academy of Sciences of the USA. 94, 3978-3983.
  • Carre, M., Carles, G., Andre, N., Douillard, S., Douillard, J., Briand, C. and Braguer, D. (2002) "Involvement of microtubules and mitochondria in the antagonism of arsenic trioxide on paclitaxel-induced apoptosis". Biochemical Pharmacology 63, 1831-1842.
  • Belzacq, A.S., El Hamel, C. Vieira, H.L., Cohen, I., Haouzi, D., Metivier, D., Marchetti, P., Brenner, C. and Kroemer, G. (2001) "Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437". Oncogene 20, 7570-7587.
  • Larochette, N., Decaudin, D., Jacotot, H. Brenner, C., Marzo, I., Susin, S.A., Zamzami, N., Xie, Z., Reed, J. and Kroemer, G. (1999) "Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore". Experimental Cell Research 249, 413-421.
  • Orlandi, L., Zaffaroni, N., Bearzatto, A., Villa, R., De Marco, C. and Silvestrini, R. (1998) "Lonidamine as a modulator of taxol activity in human ovarian cancer cells: effects on cell cycle and induction of apoptosis". International Journal of Cancer 78, 377-384.
  • Miccoli, L., Poirson-Bichat, F., Sureau, F., Bras-Goncalves, R., Bourgeois, Y., Dutrillaux, B., Poupon, M.F. and Oudard, S. (1998) "Potentiation of lonidamine and diazepam, two agents acting on mitochondria, in human glioblasloma treatment". Journal of Natural Cancer Institute 90, 1400-1406.
  • Pacini, P., Rinaldini, M., Algeri, R., Guarneri, A., Tucci, E., Barsantin, G., Neri, B., Bustiani, P., Marzano, S. and Fallai, C. (2000) "FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results". European Journal of Cancer 36, 966-975.
  • De Lena, M., Lorusso, V., Bottalico, C., Brandi, M., De Mitrio, A., Catino, A., Guida, M., Latorre, A., Leone, B., Vallejo, C. and Gargano, G. (1997) "Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinum". Journal of Clinical Oncology 15, 3208-3213.
  • Tura, S., Cavo, M., Gobbi, M. and Franchi, P. (1984) "Lonidamine in the treatment of chronic lymphoid leukemia". Oncology 41(Suppl. 1), 90-93.
  • Sandrelli, A., De Fabritiis, P., Capua, A., Mandelli, F., Zupi, G. and Leonetti, C. (1992) "Pharmacological purging of syngeneic bone marrow ex vivo: effect of treatment with doxorubicin and lonidamine on normal and leukaemic cells of DBA/2 mice". European Journal of Cancer 28A, 1633-1636.
  • Floridi, A., Paggi, M.G., Marcante, M.L., Silvestrini, B., Caputo, A. and De Martino, C. (1981) "Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells". Journal of National Cancer Institute 66, 497-499.
  • Ravagnan, L., Marzo, L. Costantini, P., Susin, S.A., Zamzami, N., Petit, P.X., Hirsch, F., Goulbern, M., Poupon, M.F., Miccoli, L., Xie, Z., Reed, J.C. and Kroemer, G. (1999) "Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition porc". Oncogene 18, 2537-2546.
  • Fomana, J.A. and Rishi, A.K. (2002) "Classical and novel retinoids: their targets in cancer therapy". Leukemia 16, 2537-2546.
  • Hsu, C.A., Rishi, A.K., Su-Li, X., Gerald, T.M., Dawson, M.I., Schiffer, C., Reichert, U., Shroot, B., Poirer, G.C and Fontana, J.A (1997) "Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway". Blood 89, 4470-4479.
  • Zhao, X., Demary, K., Wong, L., Vaziri, C., McKenzie, A.B., Eberlein, T.J. and Spanjaard, R.A. (2001) "Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN)". Cell Death and Differentiation 8, 878-886.
  • Hail, Jr. N., Youssef, E.M. and Lotan, R. (2001) "Evidence supporting a role for mitochondrial respiration in apoptosis induction by the synthetic retinoid CD437". Cancer Research 61, 6698-6702.
  • Zang, Y., Beard, R.L., Chandraratna, R. A. and Kang, J.X. (2001) "Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells". Cell Death and Differentiation 8, 477-485.
  • Marchetti, P., Zamzami, N., Joseph, B., Schraen-Maschke, S., Mereau-Richard, C., Costantini, P., Metivjer, D., Susin, S.A., Kroemer, G. and Formstecher, P. (1999) "The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus". Cancer Research 59, 6257-6266.
  • Zamzami, N., Maro, I., Susin, S.A., Brenner, C., Larochette, N., Marchetti, P., Reed, J., Kofler, R. and Kroemer, G. (1998) "The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition". Oncogene 16, 1055-1063.
  • Kolb, J.P. (2000) "Mechanisms involved in the pro- and anti-apoplotic role of NO in human leukemia". Leukemia 14, 1685-1694.
  • Giulivi, C., Poderoso, J.J. and Boveris, A. (1998) "Production of nitric oxide by mitochondria". Journal of Biological Chemistry 273, 11038-11043.
  • Chester, M.W., Cooper, J.M., Darley-Usmar, V.M., Moncada, S. and Schapira, A.H. (1994) "Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide Implications for neurodegenerative diseases". FEBS Letters 345, 50-54.
  • Cadenas, E., Poderoso, J.J., Antunes, F. and Boveris, A. (2001) "Analysis of the pathways of nitric oxide utilization in mitochondria". Free Radical Research 33, 747-756.
  • Boyd, C.S. and Cadenas, E. (2002) "Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis". Biological Chemistry 383, 411-423.
  • Millet, A., Bettaieb, A., Renaud, F., Prevotat, L., Hammann, A., Solary, E., Mignotte, B. and Jeannin, J.F. (2002) "Influence of the nitric oxide donor glyceryl trinitrate on apoptotic pathways in human colon cancer cells". Gastroenterology 123, 2, 35-246.
  • Pfeiffer, D.R., Gudz, T.I., Novgorodov, S.A. and Erdahl, W.I., (1995) "The peptide mastoparan is a potent facilitator of the mitochondrial permeability transition". Journal of Biological Chemistry 270, 4923-4932.
  • Oren, Z., Ramesh, J., Avrahami, D., Suryaprakash, N., Shai, Y. and Jelinek, R. (2002) "Structures and mode of membrane interaction of a short alpha helical lytic peptide and its diastereomer determined by NMR, FTIR, and fluorescence spectroscopy". European Journal of Biochemisty, 269, 3869-3880.
  • Matsuzaki, K., Murase, O., Fujii, N. and Miyajima, K. (1995) "Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore". Biochemistry 34, 6521-6526.
  • Ellerby, H.M., Arap, W., Ellerby, L.M., Kain, R., Andrusiak, R., Rio, G.D., Krajewski, S., Lombardo, C.R., Rao, R., Ruoslahti, H., Bredesen, D.E. and Pasqualini, R. (1999) "Anti-cancer activity of targeted pro-apoptotic peptides". Nature Medicine 5, 1032-1038.
  • Mai, J.C., Mi, Z., Kim, S.H., Ng, B. and Robbins, P.D. (2001) "A proapoptotic peptide for the treatment of solid tumors". Cancer Research 61, 7709-7712.
  • del Rio, G., Castro-Obregon, S., Rao, R., Ellerby, H.M and Bredesen, D.E. (2001) "APAP, a sequence-pattern recognition approach identifies substance P as a potential apoptotic peptide". FEBS Letters 494, 213-219.
  • Jacotot, E., Ferri, K.F., El Hamel, C., Brenner, C., Druillennec, S., Hoebeke, J., Rustin, P., Metivier, D., Lenoir, C., Geuskens, M., Vieira, H.L., Loeffler, M., Belzacq, A.S., Briand, J.P., Zamzami, N., Edelman, L., Xie, Z.H., Reed, J.C., Roques, B.P. and Kroemer, G. (2001) "Control of mitochondrial membrane permeabilization by adenine nucltotide translocator interacting with HlV-1 viral protein rR and Bcl-2". Journal of Experimental Medicine 193, 509-519.
  • D'Agostino, D.M., Ranato, L., Arrigoni, C., Cavallari, I., Belleudi, F., Torrisi, M.R., Silic-Benussi, M., Ferro, T., Petronilli, V., Marin, O., Chieco-Bianchi, L., Bernardi, P. and Ciminale, V. (2002) "Mitochondrial alterations induced by the p13II protein of human T-cell leukemia virus type 1: critical role of arginine residues". Journal of Biological Chemistry Jul 1, [epub ahead of print].
  • Takada, S., Shirokata, Y., Kaneniwa, N. and Koike, K. (1999) "Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death". Oncogene 18, 6965-6973.
  • Banerjee, D. (2001) "Genasense (Genta Inc)". Current Opinion of Investigated Drugs 2, 574-580.
  • Jansen, B., Schlagbauer-Wadl, H., Brown, B.D., Bryan, R.N., van Elsas, A., Muller, M., Wolff, K., Eichler, H.G. and Pehamberger, H. (1998) "Bcl-2 anyisense therapy chemosensitizes human melanoma in SCID mice". Nature Medicine 4, 232-234.
  • Jansen, B., Wacheck, V., Heere-Ress, E., Schlagbauer-Wadl, H., Hoeller, C., Lucas, T., Hoermann, M., Hollenstein, U., Wolff, K. and Pehamberger, H. (2000) "Chemosensitisation of malignant melanoma by BCL2 antisense therapy". Lancet 356, 1728-1733.
  • Waters, J.S., Webb, A., Cunningham, D., Clarke, P.A., Raynaud, K. di Stefano, F. and Cotter, F.E. (2000) "Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleolide therapy in patients with non-Hodgkin's lymphoma". Journal of Clinical Oncology 18, 1812-1823.
  • Chi, K.N., Gleave, M.E., Klasa, R., Murray, N., Bryce, C., Lopes de Menezes, D.E., D'Aloisio, S. and Tolcher, A.W. (2001) "A phase 1 dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer". Clinical Cancer Research 7, 3920-3927.
  • Piche, A., Grim, J., Rancourt, C., Gomez-Navarro, J., Reed, J.C. and Curiel, D.T. (1998) "Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7". Cancer Research 58, 2134-2140.
  • Aqeilan, R., Yarkoni, S. and Lorberboum-Galski, H. (1999) "Interleukin 2-Bax: a novel prototype of human chimeric proteins for targeted therapy". FEBS Letters 457, 271-276.
  • Belostotsky, R. and Lorberboum-Galski, H. (2001) "Apoptosis-inducing human-origin Fcepsilon-Bak chimeric proteins for targeted elimination of mast cells and basophils: a new approach for allergy treatment". Journal of Immunology 167, 4719-4728.
  • Holinger, E.P., Chittenden, T. and Lutz, R.J. (1999) "Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases". Journal of Biological Chemistry 274, 13298-13304.
  • Schimmer, A.D. Hedley, D.W., Chow, S., Pham, N.A., Chakrabatty, A., Bouchard, D., Mak, T.W. Trus, M.R. and Minden, M.D. (2001) "The BH3 domain of BAD fused to the Antennapedia peptide induces apoptosis via its alpha helical structure and independent of Bcl-2". Cell Death and Differentiation 8, 725-733.
  • Vieira, H.L., Boya, P., Cohen, I., El Hamel, C., Haouzi, D., Druillenec, S., Belzacq, A.S., Brenner, C., Roques, B. and Kroemer, G. (2002) "Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-X(L)". Oncogene 21, 1963-1977.
  • Wang, J.L., Zhang, Z.J., Choksi, S., Shan, S., Lu, Z., Croce, C.M., Alnemri, E.S., Korngold, R. and Huang, Z. (2000) "Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells". Cancer Research 60, 1498-1502.
  • Wang, J.L., Liu, D. Thang, Z.J., Shan, S., Han, X., Srinivasula, SM., Croce, C.M., Alnemri, E.S and Huang, Z. (2000) "Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells". Proceeding of the National Academy of Sciences of the USA 97, 7124-7129.
  • Degterev, A., Lugovskoy, A., Cardone, M., Mulley, B., Wagner, G., Mitchison, T. and Yuan. J (2001) "Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL". Nature Cell Biology 3, 173-182.
  • Tzung, S.P., Kim, K.M., Basanez, G., Giedt, C.D., Simon, J., Zimmerberg, J., Zhang, K.Y. and Hockenbery, D.M. (2001) "Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3". Nature Cell Biology 3, 183-191.
  • Kim, K.M., Giedt, C.D., Basanez, G., O'Neill, J.W., Hill, J.J., Han, Y.H., Tzung, S.P. Zimmerberg, J., Hockenbery, D.M. and Zhang, K.Y. (2001) "Biophysical characterization of recombinant human Bcl-2 and its interactions with an inhibitory ligand. antimycin A". Biochemistry 40, 4911-4922.
  • Koh, H., Lee, K.H. Kim, D., Kim, S., Kim, J.W. and chung, J. (2000) "Inhibition of Akl and its anti-apoptotic activities by tumor necrosis factor-induced protein kinase C-related kinase 2 (PRK2) cleavage". Journal of Biological Chemistry 275, 34451-34458.
  • Filomenko, R., Poirson-Bichat, F., Billerey, C., Belon, J.P. Garrido, C., Solary, E. and Bettaieb, A. (2002) "Atypical protein kinase C zeta as a taraet for chemosensitization of tumor cells". Cancer Research 62, 1815-1821.
  • Banker, D.E., Cooper, J.J. Fennell, D.A., Willman, C.L., Appelbaum, F.R. and Cotter, F.E. (2002) "PKI1195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism". Leukemia Research 26, 91-106.
  • Hirsch, T., Decaudin, D., Susin, S.A., Marchetti, P., Larochette, N., Resche-Rigon, M. and Kroemer, G (1998) "PKI1195, a ligand of the mitochondrial benzodia/epine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection". Experimental Cell Research 241, 426-434.
  • Decaudin, D., Castedo, M., Nemati, F., Beurdeley-Thomas, A., De Pinieux, G., Caron, A., Pouillart, P., Wijdenes, J., Rouillard, D., Kroemer, G. and Poupon, M.F (2002) "Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo". Cancer Research 62, 1388-1393.
  • Casellas, P., Galiegue, S and Basile, A.S. (2002) "Peripheral benzodiazepine receptors and mitochondrial function". Neurochemistry International 40, 475-486.
  • Kessel, D., Antolovich, M. and Smith, K.M. (2001) "The role of the peripheral benzodiazepine receptor in the apoplotic response to photodynamic therapy". Photochemistry and Photobiology 74, 346-349.
  • Morris, R.L., Varnes, M.E., Kenney, M.E., Li, Y.S., Azizuddin, K., McEnery, M.W. and Oleinick, N.L. (2002) "The peripheral benzodiazepine receptor in photodynamic therapy with the phthalocyanine photosensitizer Pc 4". Photochemistry and Photobiology 75, 652-661.
  • Kessel, D. and Horwitz, J.P. (2001) "Pro-apoptotic interactions between XK469 and the peripheral benzodiazepine receptor". Cancer Letters 168, 141-144.
  • Watabe, M., Machida, K. and Osada, H. (2000) "MT-21 is a synthetic apoptosis inducer that directly induces cytochrome c release from mitochondria". Cancer Research 60, 5214-5222.
  • Belzacq, A.S., Jacotot, E., Vieira, H.L., Mistro, D., Granville, D.J., Xie, Z., Reed, J.C., Kroemer, G. and Brenner, C. (2001) "Apoptosis induction by the photosensitizer verteportin: identification of mitochondrial adenine nucleotide translocator as a critical target". Cancer Research 61, 1260-1264.
  • Squires, K.E. (2001) "An introduction to nucleoside and nucleotide analogues". Antiviral Therapy 6(Suppl. 3), 1-14.
  • Segal-Bendirdjian, K., Coulaud, D., Roques, B.P. and Le Pecq, J.B. (1988) "Selective loss of mitochondrial DNA after treatment of cells with ditercalinium (NSC 335153), an antitumor bisintercalating agent". Cancer Research 48, 4982-4992.
  • [137| Rowe, T.C. Weissig, V. and Lawrence, J.W. (2001) "Mitochondrial DNA metabolism targeting drugs". Advances in Drug Delivery Review 49, 175-187.
  • Schneider Berlin, K.R., Ammini, C.V. and Rowe, T.C. (1998) "Dequalinium induces a selective depletion of mitochondrial DNA from HeLa human cervical carcinoma cells". Experimental Cell Research 245, 137-145.
  • Modica-Napolitano, J.S., Koya, K., Weisberg, E., Brunelli, B.T., Li, Y. and Chen, L.B. (1996) "Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077". Cancer Research 56, 544-550.
  • Weisberg. L., Koya, K., Modica-Napolitano, J., Li, Y. and Chen, L.B. (1996) "In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function". Cancer Research 56, 551-555.
  • Fellous, R., Coulaud, D., et Abed, I. Roques, B.P., Le Pecq, J.B., Delain, E. and Gouyette, A. (1988) "Cytoplasmic accumulation of ditercalinium in rat hepatocytes and induction of mitochondrial damage". Cancer Research 48, 6542-6549.
  • Micheau, O., Solary, E., Hammann, A., Martin, P. Dimanche-Boitrel, M.T. (1997) "Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity" Journal of National Cancer Institute, 89, pp. 783-789.
  • Lacour, S., Hammann, A., Wotawa, A., Corcos, L., Solary, E., and Dimanche Boitrel, M.T. (2001) "Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-indudng ligand-mediated caspase-8 activation and apoptosis". Cancer Research 61, 1645-1651.
  • Fulda, S. Wick, W., Weller, M. Debatin, K.M. (2002) "Smac agonists sensitive for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo". Nature Medicine, 8, pp. 808-815.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.